Advertisement
News
Subscribe to MDT Magazine News

IME & Elta Systems to develop TSV silicon interposers for Power Amplifier applications

March 7, 2011 10:35 pm | by I-Micronews | Comments

Enables smaller, faster, lighter and more thermally-efficient multi-chip modules for high performance wireless applications.

March of Dimes provides $2.4 million in new funding for preterm birth research

March 7, 2011 8:34 pm | by EurekAlert | Comments

(March of Dimes Foundation) The work of five researchers will be supported for the next three years by new March of Dimes Prematurity Research Initiative grants. The nearly $2.4 million in new grants is being given out by the March of Dimes to support scientific efforts to predict and...

TOPICS:

"Gastric Pacemaker" Fakes Fullness as You Eat

March 7, 2011 7:35 pm | by Massachusetts Institute of Technology | Comments

Implant could be an alternative to gastric bypass surgery.

TOPICS:
Advertisement

Making Genome Sequencing Part of Clinical Care

March 7, 2011 7:33 pm | by Massachusetts Institute of Technology | Comments

A new program takes the research out of genomics.

TOPICS:

IPC 4Q profit rises 31 pct on boost in patients

March 7, 2011 12:45 pm | by The Associated Press | Comments

IPC The Hospitalist Company Inc., a provider of in-hospital medical services, said Monday that its fourth-quarter profit rose 31 percent on a boost in patients.Profit rose to $7 million, or 42 cents per share, compared with $5.4 million, or 32 cents per share, a year ago. Revenue grew 18...

Reportlinker Adds Proteomics - Technologies, Markets and Companies

March 7, 2011 11:35 am | by Bio-Medicine.Org | Comments

NEW YORK, March 7, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Proteomics - Technologies, Markets and Companies http://www.reportlinker.com/p0203550/Proteomics---Technologies-Markets-and-Companies.html Summary This report describes...

TOPICS:

Reportlinker Adds Gene Therapy - Technologies, Markets and Companies

March 7, 2011 11:34 am | by Bio-Medicine.Org | Comments

NEW YORK, March 7, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Gene Therapy - technologies, markets and companies http://www.reportlinker.com/p0203543/Gene-Therapy---technologies-markets-and-companies.html Summary Gene therapy can be...

TOPICS:

Humana CEO sees 2010 compensation slide 6 percent

March 7, 2011 10:45 am | by TOM MURPHY - AP Business Writer - Associated Press | Comments

Health insurer Humana Inc. paid Chairman and CEO Michael B. McCallister 6 percent less last year than in 2009, as a decline in option awards outweighed a bump up in the long-standing executive's performance-related bonus.McCallister, 58, received 2010 compensation valued at $6.1 million from...

Advertisement

NIH study examines best time for healthy HIV-infected people to begin antiretrovirals

March 7, 2011 10:38 am | by EurekAlert | Comments

(NIH/National Institute of Allergy and Infectious Diseases) A major new clinical trial seeks to determine whether HIV-infected asymptomatic individuals have less risk of developing AIDS or other serious illness if they begin taking antiretrovirals sooner rather than later, based on...

TOPICS:

Psoriasis medication rises hope in the fight against multiple sclerosis

March 7, 2011 9:37 am | by EurekAlert | Comments

(Ruhr-University Bochum) Fumaric acid salts have been in use against severe psoriasis for a long time. About ten years ago, researchers in Bochum speculated that they may also have a favorable effect on multiple sclerosis as a result of their TH2 polarizing mechanisms. In parallel...

TOPICS:

Genzyme seeks shareholder OK on Sanofi deal

March 7, 2011 9:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Genzyme Corp. said its board of directors unanimously recommends that shareholders accept the Sanofi-aventis revised tender offer to purchase all outstanding shares of Genzyme common stock for $74 and one contingent value right, per share.

Capacity expansion at OSRAM Opto Semiconductors

March 7, 2011 9:37 am | by I-Micronews | Comments

Conversion and expansion of chip manufacture at the Penang and Regensburg plants.

6? wafer capability for CPV solar applications

March 7, 2011 9:37 am | by I-Micronews | Comments

IQE are being recognised for developing epitaxial processes for producing high efficiency, triple junction concentrator photovoltaic (CPV) solar cells with comparable results on both 6 inch diameter germanium (Ge) and gallium arsenide (GaAs) substrates.

Repligen returns disappointing bipolar drug trial results

March 7, 2011 9:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Repligen Corp. has announced its Phase 2b clinical trial results of a bipolar depression drug candidate, and the results for RG2417 did not show significant improvement in patients with bipolar depression.

IRIDEX to Present at the Roth OC Growth Stock Conference in Dana Point, CA

March 7, 2011 9:35 am | by Bio-Medicine.Org | Comments

MOUNTAIN VIEW, Calif., March 7, 2011 /- IRIDEX Corporation (Nasdaq: IRIX ) today announced that management is scheduled to make an investor presentation at the ROTH 23rd Annual OC Growth Stock Conference on Monday, March 14, at 2:30 pm Pacific Time.  The conference is being held...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading